内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

2021 IAMGSD实践指南：糖原贮积病V & VII（McArdle病和Tarui病）

2021-10-28 国际肌糖原贮积协会 Neuromuscul Disord

糖原贮积病遗传代谢性疾病

2021年10月，国际肌糖原贮积协会研究组发布了糖原贮积病V & VII（McArdle病和Tarui病）管理指南。本文主要针对糖原贮积病V & VII的诊断和治疗提供最新指导建议。

中文标题：

2021 IAMGSD实践指南：糖原贮积病V & VII（McArdle病和Tarui病）

英文标题：

Clinical practice guidelines for Glycogen Storage Disease V & VII (McArdle disease and Tarui disease) from an international study group

发布机构：

国际肌糖原贮积协会

发布日期：

2021-10-28

简要介绍：

2021年10月，国际肌糖原贮积协会研究组发布了糖原贮积病V & VII（McArdle病和Tarui病）管理指南。本文主要针对糖原贮积病V & VII的诊断和治疗提供最新指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 IAMGSD实践指南：糖原贮积病V+&+VII（McArdle病和Tarui病）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=887c41c0022816d4, title=2021 IAMGSD实践指南：糖原贮积病V & VII（McArdle病和Tarui病）, enTitle=Clinical practice guidelines for Glycogen Storage Disease V & VII (McArdle disease and Tarui disease) from an international study group, guiderFrom=Neuromuscul Disord, authorId=0, author=, summary=2021年10月，国际肌糖原贮积协会研究组发布了糖原贮积病V & VII（McArdle病和Tarui病）管理指南。本文主要针对糖原贮积病V & VII的诊断和治疗提供最新指导建议。, cover=https://img.medsci.cn/2021122/1638452672534_1608702.png, journalId=0, articlesId=null, associationId=2195, associationName=国际肌糖原贮积协会, associationIntro=国际肌糖原贮积协会(IAMGSD,International Association for Muscle Glycogen Storage Disease), copyright=0, guiderPublishedTime=Thu Oct 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月，国际肌糖原贮积协会研究组发布了糖原贮积病V &amp; VII（McArdle病和Tarui病）管理指南。本文主要针对糖原贮积病V &amp; VII的诊断和治疗提供最新指导建议。</span></p>, tagList=[TagDto(tagId=86889, tagName=糖原贮积病), TagDto(tagId=118027, tagName=遗传代谢性疾病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=86889, guiderKeyword=糖原贮积病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1758, appHits=48, showAppHits=0, pcHits=463, showPcHits=1709, likes=0, shares=2, comments=3, approvalStatus=1, publishedTime=Thu Dec 02 22:19:14 CST 2021, publishedTimeString=2021-10-28, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Dec 02 21:50:45 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Thu Jan 04 00:03:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 IAMGSD实践指南：糖原贮积病V+&+VII（McArdle病和Tarui病）.pdf)])
2021 IAMGSD实践指南：糖原贮积病V+&+VII（McArdle病和Tarui病）.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082564, encodeId=a6801082564ad, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:24:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076411, encodeId=35b110e641185, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 03 06:21:12 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076391, encodeId=a7de10e63913d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c335695880, createdName=ms1000001595125868, createdTime=Thu Dec 02 23:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-21 杨云姣

    ！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082564, encodeId=a6801082564ad, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:24:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076411, encodeId=35b110e641185, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 03 06:21:12 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076391, encodeId=a7de10e63913d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c335695880, createdName=ms1000001595125868, createdTime=Thu Dec 02 23:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-03 RENYUQIONG200798

    好好学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082564, encodeId=a6801082564ad, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:24:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076411, encodeId=35b110e641185, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 03 06:21:12 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076391, encodeId=a7de10e63913d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c335695880, createdName=ms1000001595125868, createdTime=Thu Dec 02 23:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 ms1000001595125868

    值得参考

    0